Innovative research to facilitate women’s health

Invent Medic develops and offers research-based products that contribute to more freedom, joy and an active lifestyle.
Read more about Invent MedicRead about Invent Medic’s share issue

Interim Report Q3 2019:

”Invent Medic to launch Efemia in major EU markets”

Newsletter December 2019

“We aim to submit an application for FDA clearance in 2020”

PR November 15, 2019

”Invent Medic launches Efemia in Norway”

Share issue in February 2020

“The share issue enables us to accelerate our expansion in Europe and the US”

After the launches in the UK, Germany and Norway in Q4 2019 and in Belgium and the Netherlands in Q1 2020, Efemia will be available in markets with more than 8 million potential users. We will then plan a launch in the United States at the same time as we develop/evaluate additional products.

Karin Bryder

CEO, Invent Medic Sweden

Q3 2019

Forecast: Potential Efemia users

  • 2018 – 0.5 million (swe)
  • 2019 – 8 million (+dan, ger, uk, nor)
  • 2020 – 15 million (+ned, bel and more eu countries)
  • 2021 – 35 million (+the us and additional countries)

The forecast is based on Invent Medic’s expansion plans and an estimation of women with bothersome SUI in each market. In studies, around 70% of the participants have stated that they see themselves continue to use Efemia.